Ideaya priced its shares below their range to raise $50m, providing exits for Alphabet, WuXi AppTec, Celgene, Roche and Novartis.

GlaxoSmithKline, Novartis and Astellas are among the investors to have celebrated an exit after cancer therapy developer Bicycle secured $60.7m in its initial public offering.

Cambridge Innovation Capital has celebrated an exit as Bicycle Therapeutics successfully lists in the US.

Freshworks has paid an undisclosed amount for the customer success management software developer, allowing Salesforce Ventures to exit.

Seek is set to exit employee scheduling software provider Ximble in an acquisition by Paycor, three years after investing $4m in the company.

Jaguar Land Rover has exited mobility rewards app developer Validated in an acquisition of undisclosed size by Moovel.

Merck & Co and Lilly Asia Ventures will exit the biotherapeutics technology developer in an acquisition by Evotec that will be sized at up to $90m.

After a year of countless exits in the ecosystem, many among the most significant yet – so much so that five nominees were not enough to recognise them all – the Award for Exit of the Year was one of the most difficult to determine.

Retail analytics software developer Profitect has agreed to a purchase by existing investor Zebra Technologies that will also enable Motorola Solutions to exit.

Enghouse has bought the video conferencing technology developer in a $40m deal that will allow Juniper Networks and Kaiser Permanente to exit.